Healthy Eating and Active Lifestyles for Diabetes (HEAL-D): study protocol for the design and feasibility trial, with process evaluation, of a culturally tailored diabetes self-management programme for African-Caribbean communities by Goff, LM et al.
1Goff LM, et al. BMJ Open 2019;9:e023733. doi:10.1136/bmjopen-2018-023733
Open access 
Healthy Eating and Active Lifestyles for 
Diabetes (HEAL-D): study protocol for 
the design and feasibility trial, with 
process evaluation, of a culturally 
tailored diabetes self-management 
programme for African-Caribbean 
communities
Louise M Goff,  1 Amanda P Moore,1 Carol Rivas,  2 Seeromanie Harding3
To cite: Goff LM, Moore AP, 
Rivas C, et al.  Healthy Eating 
and Active Lifestyles for 
Diabetes (HEAL-D): study 
protocol for the design and 
feasibility trial, with process 




communities. BMJ Open 
2019;9:e023733. doi:10.1136/
bmjopen-2018-023733
 ► Prepublication history for 
this paper is available online. 
To view these files, please visit 
the journal online (http:// dx. doi. 
org/ 10. 1136/ bmjopen- 2018- 
023733). 
Received 20 April 2018
Revised 18 December 2018
Accepted 8 January 2019
1Diabetes and Nutritional 
Sciences, Kings College London, 
London, UK
2Faculty of Health Sciences, 
University of Southamptom, 
Southamptom, UK
3Diabetes & Nutritional Sciences 
Division, King's College London, 
London, UK
Correspondence to
Dr Louise M Goff;  
 louise. goff@ kcl. ac. uk
Protocol
© Author(s) (or their 
employer(s)) 2019. Re-use 
permitted under CC BY. 
Published by BMJ.
AbstrACt
Introduction Black British communities are 
disproportionately burdened by type 2 diabetes (T2D) and 
its complications. Tackling these inequalities is a priority 
for healthcare providers and patients. Culturally tailored 
diabetes education provides long-term benefits superior 
to standard care, but to date, such programmes have 
only been developed in the USA. The current programme 
of research aims to develop the Healthy Eating and 
Active Lifestyles for Diabetes (HEAL-D) culturally tailored 
T2D self-management programme for black British 
communities and to evaluate its delivery, acceptability and 
the feasibility of conducting a future effectiveness trial of 
HEAL-D.
Methods and analysis Informed by Medical Research 
Council Complex Interventions guidance, this research 
will rigorously develop and evaluate the implementation 
of the HEAL-D intervention to understand the feasibility 
of conducting a full-scale effectiveness trial. In phase 
1, the intervention will be developed. The intervention 
curriculum will be based on existing evidence-based T2D 
guidelines for diet and lifestyle management; codesign 
methods will be used to foster community engagement, 
identify the intervention’s underpinning theory, identify 
the optimal structure, format and delivery methods, 
ascertain adaptations that are needed to ensure cultural 
sensitivity and understand issues of implementation. In 
phase 2, the intervention will be delivered and compared 
with usual care in a feasibility trial. Process evaluation 
methods will evaluate the delivery and acceptability of 
HEAL-D. The effect size of potential primary outcomes, 
such as HbA1c and body weight, will be estimated. The 
feasibility of conducting a future effectiveness trial will 
also be evaluated, particularly feasibility of randomisation, 
recruitment, retention and contamination.
Ethics and dissemination This study is funded by a 
National Institute of Health Research Fellowship (CDF-
2015-08-006) and approved by National Health Service 
Research Ethics Committee (17-LO-1954). Dissemination 
will be through national and international conferences, 
peer-reviewed publications and local and national clinical 
diabetes networks.
trial registration number NCT03531177; Pre-results.
IntroduCtIon 
Type 2 diabetes (T2D) affects approximately 
3 million people in England and consumes 
around 10% of the National Health Service 
(NHS) budget, estimated at almost £9 billion 
in 2011 and predicted to rise to 17% of the 
NHS budget by 2035.1 Diabetes and its asso-
ciated complications place an illness burden 
on patients and carers, which dispropor-
tionately affects those from ethnic minority 
backgrounds.2 The estimated prevalence of 
T2D is up to three times higher for black 
British communities compared with white 
strengths and limitations of this study
 ► This study employs rigorous complex intervention 
methodology to develop and evaluate a culturally 
tailored diabetes self-management intervention.
 ► Participatory codesign methods are being used 
to foster stakeholder engagement in intervention 
development.
 ► The Capability, Opportunity, Motivation and 
Behaviour change framework is being used to 
identify appropriate intervention behaviour change 
techniques.
 ► Process evaluation measures are being collected to 
assess the feasibility of evaluating the intervention 
in a full-scale trial.
 ► The feasibility trial is designed to estimate the effect 
size of the intervention rather than efficacy, which 
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Europeans.3 T2D occurs, on average, 10 years earlier in 
black British people, the mean age of diagnosis is 48 years 
and approximately 25% of patients are under the age of 
40 years.4 Furthermore, glycaemic control is worse at the 
time of diagnosis and requires greater medical manage-
ment, and poorer outcomes are evident.5–7 The reasons 
for these disparities are not fully understood; while biolog-
ical factors are involved, it is understood that a range of 
behavioural, lifestyle and health system factors play a role. 
Tackling these inequalities is a healthcare priority.8 9 
Individuals of black British ethnicity form the second 
largest ethnic minority population in the UK; around 
4% of the population self-identify from this ethnic back-
ground.10 Around half of individuals are of black African 
ancestry and a third of black Caribbean ancestry.10 
Growth in the black British communities is relatively 
recent, beginning mainly in response post-Second World 
War appeals to citizens of the Commonwealth regions 
to assist with gaps in its labour market. This prompted a 
large influx of migrants in the 1950s from the Caribbean 
islands, particularly Jamaica. Migration from the African 
continent has been more recent, peaking around the 
1980s; migrants from African nations currently form the 
largest growing ethnic minority group in the UK popu-
lation.11 In some regions, such as London, black British 
communities may represent 30%–40% of the local popu-
lation and are therefore a ‘majority-minority’ community. 
Other demographic patterns are recognised; the age 
distribution of the black African and black Caribbean 
communities differs, with a larger proportion of black 
Caribbeans being aged 65 years and over, while in the 
black African population, a greater proportion are chil-
dren and young adults. High rates of unemployment are 
evident, averaging around 12% compared with 4% in the 
white British population.11
Poor access to diabetes healthcare is a significant issue 
for minority ethnic groups.2 In the UK, the NHS provides 
care to all UK residents that is free at the point of delivery. 
First-line diabetes management is situated in primary care 
and aims to promote patient involvement and self-man-
agement,12 enabling patients to adopt a healthy lifestyle 
and to manage their diabetes through support and educa-
tion.13 To achieve this, UK T2D management guidelines 
recommend that all patients attend a structured educa-
tion course to teach them the principals of T2D self-man-
agement and that this be offered annually from the 
time of diagnosis.14 Courses are recommended to use a 
group structure; typically they use face-to-face delivery by 
a diabetes specialist nurse or dietitian, with lay educator 
codelivery in some cases.14 Referral to such courses is 
audited and incentivised through the Quality Outcomes 
Framework.15 Ethnic minority groups report finding it 
more difficult to access primary care services16 and are 
more likely to report that they have not had the oppor-
tunity to attend a diabetes education course than white 
populations.17 Specifically, African-Caribbean (AfC) 
communities often report a distrust of medical advice and 
a desire for natural, non-pharmacological therapies.18 
Furthermore, healthcare professionals are perceived 
as lacking cultural understanding19 and their advice as 
lacking cultural relevance20 or being poorly adapted to 
culture and needs,18 despite their intentions; these issues 
may contribute to the poorer diabetes outcomes and 
increased morbidity experienced by AfC patients.
Culturally tailored healthcare is proposed to be one 
of the main ways in which healthcare disparities can be 
addressed21–23 and is identified as a priority by patients.8 
Culturally tailored diabetes education has demonstrated 
greater improvements in diabetes control and knowledge 
than usual care, and the benefits are maintained long 
term.22 24 Culture is a concept that is notoriously difficult 
to define, but generally, within healthcare, it is thought 
of as ‘a set of attitudes, values, beliefs and behaviours 
shared by a group of people, communicated from one 
generation to the next’.25 In their model for under-
standing cultural sensitivity in healthcare, Resnicow et al26 
described two dimensions in culture: surface and deep 
structures. Tailoring interventions to surface structures 
involves matching materials and messages to observable, 
‘superficial’ characteristics of a target population, for 
example, language and food, familiar to, and preferred 
by, the target audience. Deep structure involves incor-
porating the cultural, social, historical, environmental 
and psychological forces that influence the target health 
behaviours in the proposed target population. Whereas 
surface structure generally increases the ‘receptivity’ 
or ‘acceptance’ of messages, deep structure conveys 
salience.26 Culture is ever evolving for any group, and it 
is important to recognise the diversity that exists within 
any one ‘cultural group’, which is particularly evident in 
migrant populations where second/third generations 
may have undergone significant acculturation. To date, 
culturally tailored interventions for the African diaspora 
have largely been based in the USA and may not trans-
late to UK healthcare structures or UK AfC communities 
whose cultural needs may be different.23
A two-phase programme of research is proposed in 
which a culturally tailored, evidence-based self-manage-
ment programme for T2D in African and Caribbean 
communities, called Healthy Eating & Active Lifestyles 
for Diabetes (HEAL-D), is developed, followed by a feasi-
bility trial. The intervention curriculum will be based on 
existing evidence-based guidelines for T2D14 27 to enable 
it to have potential to be embedded into clinical practice; 
codesign methods will be used to identify the optimal 
structure, format and methods of delivery and to ascer-
tain appropriate adaptations that are needed to ensure 
cultural sensitivity of the content. The purpose of this 
article is to present the protocol for the development and 
feasibility trial of HEAL-D.
Purpose and aims
The overall aims of this research are to develop a culturally 
tailored, evidence-based self-management programme 








pen: first published as 10.1136/bmjopen-2018-023733 on 1 March 2019. Downloaded from 
3Goff LM, et al. BMJ Open 2019;9:e023733. doi:10.1136/bmjopen-2018-023733
Open access
care, called HEAL-D, and to determine the feasibility of 
evaluating HEAL-D through a future effectiveness trial.
The objectives are to:
1. Develop a self-management programme, based on ex-
isting evidence-based diet and lifestyle guidelines, ap-
propriately tailored for AfC patients through codesign 
methods.
2. Establish the feasibility of conducting an effectiveness 
trial of HEAL-D, considering issues such as participa-
tion rates and potential effect sizes.
MEthods And AnAlysIs
Guided by the Medical Research Council’s Complex 
Interventions framework28 (figure 1), two distinct phases 
of research are proposed: phase 1 is a formative phase in 
which the HEAL-D intervention will be developed; and 
phase 2 will evaluate the HEAL-D intervention in a feasi-
bility trial. Study recruitment began in April 2017; the 
study duration will be 36 months.
Phase 1: development of a culturally tailored t2d self-
management programme
The process for the development of HEAL-D is outlined 
in figure 2. First, to ensure its potential to be embedded 
into future clinical practice, the HEAL-D curriculum will 
align with existing UK management recommendations 
and guidelines published by the National Institute of 
Clinical Excellence and Diabetes UK14 27:
Guidelines for diet and lifestyle management of T2D27:
1. Achieve 5%–10% wt loss or weight maintenance in 
those of healthy weight.
2. Undertake 150 min/week of moderate-to-vigorous in-
tensity aerobic physical activity plus two sessions/week 
of strength training.
3. Balance carbohydrate intakes through portion control 
and promotion of low glycaemic index and wholegrain 
sources.
4. Limit saturated fat intake (<10% of energy intake), re-
place with monounsaturated fats.
5. Limit salt intake (<6 g per day).
6. Consume oily fish at least twice per week.
Guidelines for T2D recommend that self-management 
structured education is offered to adults with T2D and/or 
their family members or carers, with group education as 
the preferred option and that the education programmes 
are theory driven and evidence based and meet the 
cultural, linguistic, cognitive and literacy needs of the 
population.14
drawing on the existing evidence base
Second, it will draw on key themes reported in published 
literature relating to methodologies for adapting health 
promotion interventions for ethnic minority groups. 
These have been evaluated in a number of recent 
systematic reviews; aside from acknowledging the lack of 
UK-based studies, these reviews make several recommen-
dations. The powerful influence of social networks on 
health beliefs and behaviours should be acknowledged,29 
and a focus on community-level interventions should 
be taken; delivering care in a social context promotes 
engagement and has been shown to be more effective than 
Figure 1 Medical Research Council’s framework for the 
development and evaluation of complex interventions. 
Reproduced from Craig et al. British Medical Journal. 2008; 
337:a1655.
Figure 2 Schematic diagram of phase I: development of 
HEAL-D using evidence synthesis and codesign methodology 
to design a culturally tailored self-management programme 
for T2D in African and Caribbean communities. HEAL-D, 
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traditional individual-centred behavioural approaches.23 
Community engagement should be promoted to over-
come issues of deep-rooted, historical distrust of medical 
advice and settings, to develop and nurture trust between 
the researchers and community and to nurture the 
strong sense of collectivism and kinship networks that 
are evident among AfC communities. Participatory 
methods (eg, patient involvement in intervention design, 
lay-led delivery of interventions) should be employed as 
they are highly effective at improving health behaviours 
and self-efficacy across a number of conditions.30 Using 
community gathering places (eg, faith institutions) as 
intervention settings offers the benefit of cultural rele-
vancy and may reach populations who would not normally 
access self-management education.31
Identifying the intervention’s theoretical basis
Behavioural interventions should have a theoretical 
underpinning28 32 so that the changes that are expected, 
and how these will be achieved, can be predicted from 
consideration of known behaviour change techniques. 
While there have been a number of interventions tailored 
to support diet and lifestyle behaviour change in AfC 
communities,33 their theoretical underpinning has rarely 
been drawn out or clearly presented. The theoretical 
underpinning of HEAL-D will be developed through a 
combination of key themes from the published literature 
and new primary research.
In the literature, collectivism and the importance 
of social interaction for people of AfC ancestry is well 
reported,29 and the provision of a social support group, 
or inclusion of a family member, has been shown to be 
particularly effective in lifestyle interventions in Afri-
can-American communities.34 35 These findings suggest 
social learning theory, which focuses on promoting 
behaviour change through social interaction, role model-
ling and social comparison, may be a relevant behaviour 
change theory for our intervention. Notably, much of 
literature that identifies the drivers of health behaviours 
in AfC communities and may, therefore, inform the theo-
retical basis of an intervention comes from the USA, 
and it is not known to what extent these findings apply 
to AfC in other regions. One of the reasons we will use 
codesign methods will be to understand the relevance 
of these existing themes to the UK context and enable 
us to identify themes that are important to black British 
communities.
Codesigning the intervention through participatory methods
HEAL-D will use participatory codesign methods to 
engage patients, healthcare providers and community 
leaders (eg, church leaders and community group leads) 
in focus groups, interviews and workshops to achieve the 
following:
1. Foster community engagement.
2. Identify the theoretical underpinning of HEAL-D and 
its mechanisms of action.
3. Identify appropriate cultural adaptations for the inter-
vention.
4. Understand issues of intervention implementation.
Focus groups and interviews
Focus groups, 8–10 groups of 6–8 participants, will be 
conducted with patients with T2D of AfC ethnicity, 
recruited through local churches, mosques and commu-
nity groups, as well as through general practitioner (GP) 
practices in London. The focus groups will be conducted 
in local accessible community venues, for example, 
church hall, library and community centre. Patients 
will be purposively sampled to get a spread of socioeco-
nomic position, generational status and ancestral origins, 
as principal factors impacting on health status, health-
care access and cultural behaviours in these groups.36–38 
Separate focus groups will be conducted with men and 
women, and patients of direct African versus Caribbean 
ancestry, as they report different cultural barriers/facili-
tators to lifestyle change.36 37 A topic guide (box 1) based 
box 1 topic guides for patient focus groups and 
stakeholder interviews
Patient focus groups
 ► Knowledge and perceptions of diabetes, and diet and lifestyle advice 
for managing diabetes.
 ► Current practices relating to diabetes self-care, and diet and lifestyle.
 ► Health concerns/priorities in relation to diabetes.
 ► Motivations and barriers/difficulties relating to diabetes self-care, 
weight management and diet and lifestyle.
 ► Experiences and perceptions of diabetes care/education and barri-
ers to accessing care.
 ► Experiences of behaviour change in relation to diabetes, weight, diet 
and lifestyle—successes and failures.
 ► Role of family/friends/communities in influencing and shaping 
knowledge and behaviours in relation to diabetes, diet and lifestyle.
Community leader interviews (including religious leaders)
 ► Health problems affecting the community and diabetes impact on 
health within this context.
 ► Attitude of the community towards health, medicines and doctors.
 ► Role of community leaders in promoting health and community 
activities.
 ► Diabetes health promotion activities within the community. What 
worked and what did not.
 ► Barriers and facilitators to positive diabetes behaviours within the 
community.
 ► Advice about engaging the community: who are the role models; 
what will engage and help people; how can healthcare and com-
munity work together.
healthcare professional interviews
 ► Experience of supporting African and Caribbean patients. What are 
the issues. How could things be improved. What factors make suc-
cessful T2D management likely.
 ► Patient beliefs and motivations.
 ► Involvement in community activities and experience of working with 
community leaders and lay educators and suggestions to improve 
partnerships.
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on themes identified in the literature will be used to steer 
discussions and ensure coverage of key themes while 
encouraging free discussion of opinion/perspective. 
Focus groups have been selected to enable us to under-
stand normative needs, as suited to the development of a 
community intervention.
Semistructured interviews will be conducted with 8–10 
healthcare providers, including general practitioners, 
practice nurses, diabetes specialist nurses, diabetes 
specialist dietitians and commissioners. The interviews 
will cover issues relating to healthcare needs and engage-
ment of AfC patients, experiences of delivering healthcare 
to AfC patients and barriers and facilitators to working in 
partnership with community groups to deliver care for 
AfC communities (box 1). Interviews have been selected 
for this part of the study to enable us to gather a full range 
of experiences and therefore optimise implementation.
Community leaders representing faith and non-faith 
institutions (n=4–6) will be invited to participate in semi-
structured interviews. Leaders will be identified initially 
through existing networks, for example, Diabetes UK 
Community Champions initiative. Word-of-mouth and 
‘snow-balling’ techniques that are highly effective within 
these communities will be used to recruit a wider network. 
The interviews will cover issues relating to the role of 
community networks in promoting health of AfC commu-
nities, sustaining health among community members and 
opportunities for greater impact (box 1).
Analysis
The focus groups and interviews will be digitally recorded 
and transcribed verbatim. The data will be analysed using 
the framework approach in NVivo (QSR International), 
theoretically driven by socioecological theory to identify 
themes relating to issues at the individual, family, commu-
nity and healthcare delivery levels and how these influ-
ence self-efficacy and behaviour change. Our analysis will 
identify priority behaviours of focus for the intervention, 
key barriers and facilitators to behaviour change and 
healthcare engagement, favoured settings and a rudi-
mentary draft of the cultural adaptations. Deviant case 
analysis, which is consideration of cases that do not fit the 
general picture, will be undertaken, though our primary 
interest is in the commonalities as this is a communi-
ty-level intervention. Primary coding and development of 
a coding scheme will be carried out by a single researcher; 
a second researcher will independently use this coding 
scheme to code 20% of the data for cross-comparison to 
improve dependability. This will provide methodological 
rigour required for confidence in the analysis of the qual-
itative data. The themes will be fed back and discussed 
with a service user group (SUG), which will consist of 
representatives of patients, healthcare providers and 
community leaders. The SUG will be set up to inform and 
guide each stage of the research plan and will be a forum 
through which the research team can seek the opinion 
of key stakeholders, in this case particularly relating to 
interpretation of the qualitative data and to ensure trust-
worthiness of conceptualisations. The SUG will also 
review research documents, such as patient information 
sheets and questionnaires, and provide feedback on their 
content and suitability for the communities of focus.
We will divide our data into behavioural ‘barriers’ and 
‘facilitators’ where possible. To ascertain appropriate 
behaviour change techniques for our intervention,32 we 
will map our analysis onto the Capability, Opportunity, 
Motivation and Behaviour (COM-B) framework from the 
Behaviour Change Wheel39 (figure 3), and then in each 
case, consider the outcome behaviours that our interven-
tion will aim to achieve; a worked example is shown in 
figure 4. We will use the COM-B framework to identify 
appropriate functions of our intervention to optimise facil-
itators and overcome barriers to achievement of planned 
outcomes, for example, ‘education’ for capability 
barriers, ‘modelling’ for opportunity and motivation 
barriers. Finally, we will select specific behaviour change 
techniques, for example, education and goal setting, that 
focus on the specific functions we have identified. We will 
also look to identify other themes that arise from the data, 
which might not map clearly onto the COM-B framework 
Figure 3 The Capability, Opportunity, Motivation and 
Behaviour (COM-B) framework and behaviour change 
wheel; a framework for developing behavioural interventions. 
Reproduced from Michie S et al. Implementation Science. 
2011; 6:42.
Figure 4 Applying the COM-B behaviour change framework 
to the development of the HEAL-D intervention; identifying 
theory of change. COM-B, Capability, Opportunity, Motivation 
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(eg, contextual themes relating to the health system) but 
which may inform our intervention theory as well as help 
us to understand issues of implementation (eg, favoured 
settings and timings). Through this analysis, we will iden-
tify our intervention theory that we will draw on for the 
next stage of the study, as documented through a logic 
diagram.
stakeholder codesign workshops
Following evaluation of the focus groups and interviews, 
our stakeholders, 12–15 patients, healthcare providers, 
commissioners and community leaders will be invited 
to participate in a series of 2–3 half-day workshops, held 
in community locations. The workshops will seek to 
gain stakeholder involvement in developing the details 
of the interventions. This will include determining the 
setting, the media channels, structure and delivery, as 
well as steering the research team to understand and 
respond to literacy and numeracy needs. The work-
shops will endeavour to reach a consensus opinion from 
attendees, but where stakeholders have different needs 
and a consensus cannot be reached, the research team 
will consult with the SUG to make decisions on the way 
forward and consider where there is scope for the inter-
vention to be structured to meet these different needs, 
for example, delivery in a range of settings. In the first 
workshop, the research team will feed back the findings 
of the focus groups and interviews; anonymised interview 
extracts will be presented to illustrate the key themes and 
issues that were identified. The stakeholders will be asked 
to discuss the themes and behavioural targets in small 
groups, using directed tasks/questions to facilitate the 
discussions. Following the small group discussions, the 
researchers will facilitate discussion as a whole to clarify/
confirm interpretation; open discussion/debate will be 
encouraged to examine the themes in depth and for all 
stakeholders to agree a mutual understanding.
In the second workshop, elements of the proposed 
intervention will be presented for comment, refining 
and development. Using scenarios, the stakeholders 
will be asked to brainstorm, in small groups, key issues 
relating to the scenarios. For example, the moderator 
will present scenarios relating to the intervention setting 
and the attendees will be asked to discuss and identify 
the pros and cons of each, and then feed back their 
discussions to the other attendees. The attendees will be 
asked to review existing educational/support materials, 
for example, leaflets and videos, and provide feedback 
on, for example, language/phrasing, content, pitch and 
understanding. The research team will then facilitate 
cross-discussion between groups to develop the conclu-
sions and a consensus.
In the final workshop, draft intervention materials, 
developed from workshops 1 and 2, will be presented. For 
example, media channels that could be used to promote 
behaviour change such as testimonials, storytelling and 
cooking demonstrations. The stakeholders will be divided 
into small groups to discuss and provide feedback on the 
acceptability of the components of the intervention and 
identify potential barriers to engagement. Following the 
small group discussions, the researchers will facilitate 
feedback and encourage discussion as a whole to clarify/
confirm the researcher’s interpretation. The intervention 
template may be further refined and will be developed 
into the detailed programme.
Phase 2: evaluation of hEAl-d; a culturally tailored t2d 
self-management programme for African and Caribbean 
communities
In phase 2, a feasibility study, with an embedded process 
evaluation, will be conducted to address the following 
objectives:
1. Evaluate the HEAL-D intervention, particularly its the-
oretical under-pinning, acceptability, fidelity, issues of 
implementation and sustainability.
2. Evaluate the feasibility of trial procedures, considering 
issues such as rates of recruitment, retention, comple-
tion and contamination.
3. Estimate the effect size of potential trial outcomes in-
cluding HbA1c, weight, waist circumference, blood 
pressure, dietary intake, physical activity levels, diabe-
tes knowledge and quality of life, to inform an effec-
tiveness trial.
study design
The feasibility study will use a randomised controlled 
design, with individual patients as the unit of randomis-
ation, evaluating HEAL-D against usual care. In addition, 
there will be a cohort of phase 1 codesign patients who will 
be allocated to the intervention arm (not randomised) 
because their involvement in the intervention design 
phase would contaminate the control arm. These patients 
will be included in the feasibility study to enable us to 
evaluate the impact of former involvement on interven-
tion engagement, acceptability and ownership.
Participants
Participants will principally be recruited from general 
practice in the London Boroughs of Lambeth and South-
wark through screening of referrals for structured educa-
tion and letters of invitation to patients with established 
T2D. In addition, participants from the phase 1 code-
sign study will be invited to participate, and self-referral 
methods will also be used, for example, posters and adver-
tisements in community locations.
Patients with diagnosed T2D who are of African or 
Caribbean ethnicity and with capacity to provide fully 
informed consent to participation in research will 
be eligible to participate in the trial. Ethnicity will be 
self-declared using the standard NHS ethnicity cate-
gorisation questionnaire. Patients who are unable to 
communicate in English and patients with complex ther-
apeutic dietary needs may be ineligible to participate if 
their individual needs are deemed incompatible with 
the aims of the intervention. This is because the inter-
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the self-management of T2D in a group setting; in cases 
of patients with certain comorbidities, for example, 
advanced renal disease, the intervention may be inap-
propriate for the individual, and the group nature of 
the intervention will prevent their individual needs from 
being addressed.
A pragmatic sample size of 120 patients is anticipated to 
be sufficient to evaluate the programme, allowing for 20% 
dropout/non-completion; 80 patients will be randomised, 
40 in each arm, and a further cohort of patients (n=40) 
from phase 1 will be allocated to the intervention arm 
without randomisation. As this is a feasibility trial, it will 
not be powered to detect statistically significant interven-
tion effects. A primary objective of the study is to provide 
estimates of key parameters such as potential effect sizes, 
recruitment and retention rates of the trial and participa-
tion rates of the programme to enable the optimal design 
of a full-scale trial to be determined.
Intervention and control arms
Participants in the control arm will continue with usual 
care deemed appropriate and delivered by their primary 
care team, which may include referral to group struc-
tured education and/or one-to-one consultations with 
healthcare professionals.
Participants in the intervention arm will be offered the 
HEAL-D programme, which will deliver a curriculum 
of culturally tailored, evidence-based diet and physical 
activity education and behaviour change in a group 
setting. In line with clinical guidelines, the programme 
will be delivered by trained educators (external to the 
research team); favoured educators (eg, lay educators vs 
healthcare professionals) will be identified in the code-
sign process. The details of each session, particularly the 
behaviour change techniques and corresponding activi-
ties/materials, will be identified through the codesign 
work.
The proposed curriculum will map to evidence-based 
guidelines and will be as follows:
1. An introduction to T2D self-management principles.
2. Physical activity in T2D management.
3. Carbohydrates and portion sizes.
4. Weight management for T2D.
5. Managing cardiovascular health.
In line with clinical guidelines for diabetes structured 
education, the education sessions will be delivered 
through educator-led interactive discussion; however, 
support materials will be provided to reinforce the 
learning, detailing evidence-based diet and physical 
activity guidance, which is culturally tailored for the 
African and Caribbean communities.
data collection
We will use a mixed methods approach, collecting a range 
of quantitative and qualitative data, to evaluate the inter-
vention and the feasibility of trial procedures.
Estimating the effect of the intervention on potential trial outcomes
Participants will attend a baseline and postintervention 
follow-up assessment visit, conducted by a research tech-
nician, at 26–32 weeks to collect the following potential 
trial outcomes and estimate effect sizes:
Biomedical outcomes: a 5 mL venous blood sample 
will be taken for analysis of HbA1c and total HDL-choles-
terol and LDL-cholesterol and triglycerides. Systolic and 
diastolic blood pressure will be measured using an auto-
mated sphygmomanometer.
Anthropometric outcomes: body weight will be 
measured using digital scales, with the patient wearing 
light clothing (without shoes); height will be measured, 
using a stadiometer, without shoes; body mass index will 
be calculated as (weight [kg]/height [m2]). Waist circum-
ference will be measured with the patient wearing only 
light clothing, at the midpoint between the lowest rib and 
the iliac crest.
Diet and physical activity behaviour outcomes: dietary 
intake will be assessed through completion of a 24-hour 
diet recall, using the structured multiple pass interview 
method, and physical activity through 3-day Actiwatch 
accelerometer assessment and completion of the Interna-
tional Physical Activity Questionnaire.
The following validated self-complete questionnaires 
will be administered to assess: diabetes knowledge 
(Short Diabetes Knowledge Instrument40); diabetes and 
diet knowledge and competence (Perceived Diabetes 
& Dietary Competence37); empowerment (Diabetes 
Empowerment Scale-Short Form41); social support 
(Multidimensional Scale of Perceived Social Support42); 
diabetes distress (problem areas in diabetes (PAID)-543); 
and quality of life (EuroQol (EQ)-5D-3L44).
Statistical analysis: given that this is a feasibility study 
with a small sample size, descriptive statistics will be used 
(χ2 test and Fisher’s exact test). Differences between the 
groups in all outcomes will be estimated with 95% CIs. 
The descriptive data will provide stable estimates of the 
variability of continuous outcomes by group and provide 
estimates of differences between the groups in means and 
proportions for the key outcomes. The SD of the mean 
change in HbA1c will be estimated by arms and used to 
derive the sample size calculation for a subsequent trial.
Evaluation of the HEAL-D intervention
Process evaluation is an essential part of testing complex 
interventions45 and will be used in our feasibility trial to 
evaluate the HEAL-D intervention and the feasibility of 
trial procedures. Our process evaluation aims to achieve 
the following:
1. Test the intervention theory and whether the mecha-
nisms of change operationalise as hypothesised.
2. Understand how the multiple components of the in-
tervention interact.
3. Evaluate contextual factors that influence operation-
alisation of the intervention’s theory/mechanisms of 
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4. Evaluate whether the intervention is differentiable 
from ‘usual practice’.
5. Evaluate implementation of the intervention, par-
ticularly ‘reach’ (eg, who receives the intervention), 
‘dose’ and completion rates, and intervention fideli-
ty (eg, coverage of core materials and learning objec-
tives during delivery, and the extent to which the pro-
gramme is delivered in accordance with the delivery 
manual, what adaptations are undertaken and why).
6. Evaluate acceptability of the intervention to patients, 
healthcare professionals and commissioners.
7. Evaluate intervention embedding and sustainabili-
ty, for example, what are the barriers and facilitators 
to the uptake of the intervention in current care 
pathways.
A range of quantitative and qualitative data will be 
collected, as detailed in table 1. Attendance records, 
observation checklists, session/programme evaluation 
forms completed by patients and records of session activi-
ties completed by educators will provide quantitative data 
and will be used to evaluate a number of process domains, 
as indicated in table 1. Our process evaluation will mainly 
focus on qualitative evaluations, with which we will use 
inductive reasoning to determine whether the inter-
vention requires further development and adaptation. 
Patient interviews and focus groups, and interviews with 
educators, healthcare professionals and commissioners, 
and session observation notes will provide qualitative 
data for the evaluation of a number of process domains, 
as detailed in table 1.
Evaluation of trial procedures
The feasibility of trial procedures will be evaluated, 
particularly rates and methods of recruitment, retention, 
completion, contamination between study arms and the 
proposed data collection methods:
Recruitment
Several different pathways of recruitment will be imple-
mented, for example, screening of primary care data-
bases and letters of invitation, face-to-face referral during 
medical appointments, self-referral via posters and word-
of-mouth referral. We will assess uptake rates from these 
different pathways to enable us to identify the most effec-
tive methods and assess the feasibility of recruiting for a 
full-scale trial.
Retention and completion
We will assess the rate of retention both within the HEAL-D 
intervention (ie, numbers completing each session and 
the full programme) and the feasibility trial (ie, numbers 
completing baseline and endpoint assessment visits). We 
will evaluate the feasibility of randomising and retaining 
a control arm by assessing dropout rates and comparing 
these between the study arms; we will also interview 
control arm patients to explore the acceptability of being 
assigned to the control arm.
Data collection methods
We will assess the frequency of missing data and any trends 
in which data is missing, for example, self-complete ques-
tionnaires, blood measures, to assess the feasibility of our 
data collection methods.
Contamination
We will interview patients from the control arm to explore 
issues of contamination, for example, did their partici-
pation in the trial promote change in self-management 
behaviours or motivate information-seeking behaviours, 
did they know anybody in the intervention arm or discuss 
the intervention with anybody.
Patient and public involvement
Service user involvement is intrinsic to this proposed 
research, which uses participatory methods to engage 
patients and other stakeholders in the intervention 
design. The protocol provides extensive detail of how 
patients will be involved in the design, recruitment, 
conduct and dissemination of the research.
Ethics and dissemination
All data will be anonymised and data protection protocols 
followed.
The study findings will be disseminated to the scientific 
community via conference presentations and peer-re-
viewed manuscripts and to healthcare professionals via 
national and local clinical networks. The findings of the 
study will be communicated to our participants and local 
communities via the community networks and figure-
heads who we will engage in our participatory methods; 
we will give presentations at church events and publish a 
newsletter via our study website ( www. heal- d. co. uk).
dIsCussIon
This paper presents the protocol for the design and 
feasibility testing of HEAL-D, a culturally tailored T2D 
self-management programme for UK African and Carib-
bean communities. This study will employ rigorous 
complex intervention methodology to develop and eval-
uate the implementation of a culturally tailored T2D 
self-management intervention. The intervention’s curric-
ulum will be based on existing evidence-based guidelines 
for diet and lifestyle management of T2D; participatory 
codesign methods will be employed to foster community 
engagement and partnership. We will use a ‘bottom-up’ 
approach to identify the cultural adaptations of our 
intervention and identify its theoretical basis through 
thematic analysis and the COM-B change framework. The 
feasibility study will provide us with key information about 
the feasibility of running a full-scale trial of HEAL-D, and 
process evaluation methods will enable us to understand 
how and why the intervention is effective or ineffective.
To date there have been no tailored education 
programmes for black British communities. Indeed, it 
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needed for black British communities as little work has 
been undertaken with these communities. Our codesign 
work is intended to explore the sociocultural barriers and 
facilitators to behaviour change and structure HEAL-D 
accordingly. We acknowledge that we are likely to find 
huge diversity within our black British communities and 
culture will likely be only one of many important factors that 
affects their health behaviours. However, our codesign work 
will provide a more comprehensive theoretical underpin-
ning for the content of our programme than that which 
currently exists and will provide us with a framework on 
which to evaluate the effectiveness of our programme. This 
work will provide essential information and evaluation to 
inform the design of a future definitive trial.
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